Home » News » Awards & Advancement » Jesper Ericsson appointed new CEO of Symcel

Jesper Ericsson appointed new CEO of Symcel

Friday, September 1, 2017

Symcel has announced that Jesper Ericsson has joined Symcel as Chief Executive Officer—with the appointment effective immediately. Ericsson was formally Director of Marketing and Sales at BioLamina, where he was responsible for direct sales both internationally and at a global and regional distributor level. During the past 10 years, Jesper has gained broad experience of the commercialization of research-based products through his work at the Unit for Bioentrepreneurship at the Karolinska Institute, Stockholm School of Entrepreneurship and as co-founder of the Stockholm BiotechBuilders Association. He holds a Ph.D. in neuroscience from the Karolinska Institute and a MSc in medical technology from the Royal Institute of Technology in Stockholm.

Jesper Ericsson commented, “I very much look forward to developing the plan and globally establishing Symcel’s solutions for phenotypic screening—with a substantial focus on sales and marketing in the coming years.”

“Jesper’s experience in selling and marketing products towards the research market will strengthen Symcel’s sales within different segments, especially for microbiology applications,” remarked Björn Varnestig, Chairman of Symcel.

“The Board wishes to thank Christer Wallin for his strong commitment and contribution over the past six years. During this time, the company’s product CalScreener has been successfully developed and launched on the market. Christer has industrialized production processes and increased quality assurance,” Björn Varnestig added.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!